ZICCUM AB First Quarter Report, Q1 2020
Summary of Interim First Quarter Report 2020: Further industrial and NGO collaborations.Summary of Interim First Quarter Report 2020 Ziccum announced a further, third collaboration with an industrial partner that is developing a new, more effective method of producing measles and rubella vaccines. The goal is to both significantly reduce the cost, and increase the availability, of these childhood vaccines. We have also signed a confidentiality agreement with an important non-governmental organization (NGO) for further and more detailed discussions about how technology can help the most